Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|November 19, 2019
Structure-Based Optimization of Coumarin hA3 Adenosine Receptor AntagonistsMaria João Matos, Santiago Vilar, Saleta Vazquez-Rodriguez, et al.Drug Safety|October 9, 2015
Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health RecordsJuan M Banda, Alison Callahan, Rainer Winnenburg, et al.Frontiers in Cell and Developmental Biology|January 7, 2021
Regulation of Mitochondrial Respiratory Chain Complex Levels, Organization, and Function by Arginyltransferase 1Chunhua Jiang, Balaji T Moorthy, Devang M Patel, et al.Bioorganic & Medicinal Chemistry|February 13, 2017
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studiesFrancesca Pintus, Maria J Matos, Santiago Vilar, et al.The Biochemical Journal|July 31, 2020
An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivityLucas A Luna, Zachary Lesecq, Katharine A White, et al.Frontiers in Chemistry|May 10, 2018
Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase InhibitorsCatarina Oliveira, Fernando Cagide, José Teixeira, et al.Journal of Biomedical Informatics|April 29, 2015
Toward a complete dataset of drug-drug interaction information from publicly available sourcesSerkan Ayvaz, John Horn, Oktie Hassanzadeh, et al.Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|February 1, 2015
[Thyroid orbitopathy, an overview with special attention to the role of radiotherapy]Santiago Vilar-González, Cristina Lamas-Oliveira, María A Fagúndez-Vargas, et al.Chemmedchem|April 17, 2013
MAO inhibitory activity of 2-arylbenzofurans versus 3-arylcoumarins: synthesis, in vitro study, and docking calculationsGiulio Ferino, Enzo Cadoni, Maria João Matos, et al.Cancer Research|April 19, 2024
GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell CarcinomaDazhi Wang, Iqbal Mahmud, Vijay S Thakur, et al.Pageof 11